METROPOLITAN LIFE INSURANCE CO/NY - TCR2 THERAPEUTICS INC ownership

TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 122 filers reported holding TCR2 THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of TCR2 THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$77,892
-48.1%
9,1530.0%0.00%
-50.0%
Q2 2021$150,201
-14.5%
9,153
+15.0%
0.00%
-33.3%
Q1 2021$175,713
-28.6%
7,9580.0%0.00%
-25.0%
Q4 2020$246,141
+52.2%
7,9580.0%0.00%
+33.3%
Q3 2020$161,707
+85.7%
7,958
+40.4%
0.00%
+50.0%
Q2 2020$87,0915,6700.00%
Other shareholders
TCR2 THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,050,865$11,748,0004.96%
MPM BioImpact LLC 3,370,982$9,776,0002.72%
TANG CAPITAL MANAGEMENT LLC 3,641,606$10,561,0001.60%
Newtyn Management, LLC 692,799$2,009,0000.38%
K2 PRINCIPAL FUND, L.P. 1,078,070$3,126,0000.34%
HARBOR CAPITAL ADVISORS, INC. 64,341$187,0000.14%
Redmile Group, LLC 1,094,645$3,174,0000.12%
Artal Group S.A. 750,000$2,175,0000.12%
Oasis Management Co Ltd. 200,000$580,0000.10%
X-Square Capital, LLC 31,919$93,0000.06%
View complete list of TCR2 THERAPEUTICS INC shareholders